Domain-Focused Intelligence
AI workflows specifically trained for pharmaceutical applications: regulatory compliance, competitive intelligence, market access, and clinical development — not general business use.
Molecule Lifecycle Intelligence
Decision Intelligence Built for Pharma
From patent cliff defense to competitive positioning, we power intelligent decisions across your entire molecule lifecycle. 75% lower cost. 10x faster. Deployed in weeks, not months.
The Intelligence Advantage
Proven impact metrics across molecule lifecycle decision intelligence.
0%Cost Reduction vs. Traditional Consulting
0xFaster Feedback Cycles
0-40%Trial Sample Size Reduction
0-6 wkDeployment Timeline
Our Philosophy
Your data should be your competitive moat
You already have the data — what's missing is coherence. In pharma, insights get stuck in silos, workflows slow down under regulatory demands, and hard-earned knowledge disappears when teams change. We turn that chaos into AI-driven clarity.
Private by Design
We never train on customer data or share insights across clients. Each AI system is built exclusively for your organization with SOC2/HIPAA/ISO/21 CFR Part 11 compliance.
Lifecycle-Aligned Solutions
AI capabilities that match the specific decisions at each phase of your molecule's journey — from discovery through loss of exclusivity, with a pay-per-molecule pricing model.
Solutions
Critical Market Dynamics We Address
Eight engagement categories where our decision intelligence delivers immediate, measurable value.
Critical
Patent Cliff Defense
War-gaming simulations and franchise transition planning for $200B+ in LOE exposure.
$108B+Revenue at risk
Critical
ADC Competitive Intelligence
Real-time monitoring across 15+ Phase 3 ADC trials and head-to-head positioning analytics.
$30B+Market by 2030
Critical
Precision Diagnostics
CDx lifecycle management and competitive intelligence across the diagnostics ecosystem.
$12B+CDx market by 2030
High
Obesity & GLP-1 Strategy
Market entry war-gaming and brand development for the $100B+ metabolic market.
$100B+TAM by 2030
High
Clinical Trial Innovation
External control arms and synthetic phenotype stratification for 30-40% trial optimization.
30-40%Sample size reduction
High
Biosimilar Defense
Patient retention modeling and franchise defense for branded products facing competition.
$322BRevenue pool
Molecule Lifecycle
Intelligence Across Every Lifecycle Stage
Our platform delivers decision intelligence at every step — from target discovery through loss of exclusivity and beyond.
A smarter way to embed AI into your business
Traditional AI solutions offer tools. Behavior Labs creates intelligence assets that compound in value across your molecule lifecycle.
Stay Updated
Get the latest updates on AI-driven pharmaceutical decision intelligence